Yahoo
Tokyo - Delayed Quote JPY

FALCO HOLDINGS Co., Ltd. (4671.T)

2,656.00 -56.00 (-2.06%)
At close: 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 4671.T
  • Previous Close 2,712.00
  • Open 2,662.00
  • Bid 2,651.00 x --
  • Ask 2,665.00 x --
  • Day's Range 2,635.00 - 2,681.00
  • 52 Week Range 2,471.00 - 2,964.00
  • Volume 18,300
  • Avg. Volume 17,616
  • Market Cap (intraday) 26.224B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 12.83
  • EPS (TTM) 206.99
  • Earnings Date (est.) --
  • Forward Dividend & Yield 128.00 (4.72%)
  • Ex-Dividend Date Mar 30, 2027
  • 1y Target Est --

FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. The company offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services for diagnosis of hereditary cancer, reproductive health and companion diagnostics. It also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs. In addition, the company is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical chart systems, including HAYATE / NEO, cloud-based electronic medical record for small and medium-sized hospitals, as well as @home Dr., an electronic medical chart for bed less clinics. FALCO HOLDINGS Co., Ltd. was founded in 1962 and is headquartered in Osaka, Japan.

www.falco-hd.co.jp

1,037

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4671.T
3.78%
Nikkei 225 (^N225)
25.31%

1-Year Return

4671.T
12.11%
Nikkei 225 (^N225)
20.36%

3-Year Return

4671.T
53.18%
Nikkei 225 (^N225)
97.44%

5-Year Return

4671.T
94.26%
Nikkei 225 (^N225)
113.69%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 11B
Earnings 385M
Profit Margin 3.50%

Q3

FY25

Q1

FY26

Q3

FY26

Q1

FY27

0
2B
4B
6B
8B
10B
3.0%
3.5%
4.0%
4.5%
5.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.76%

  • Return on Assets (ttm)

    4.38%

  • Return on Equity (ttm)

    8.33%

  • Revenue (ttm)

    43.65B

  • Net Income Avi to Common (ttm)

    2.08B

  • Diluted EPS (ttm)

    206.99

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.68B

  • Total Debt/Equity (mrq)

    4.03%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: